PHAXIAM Therapeutics S.A.
PHXM · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23,488 | -$228 | -$53,797 | -$73,300 |
| Dep. & Amort. | $1,608 | $2,908 | $5,377 | $4,991 |
| Deferred Tax | -$208 | $521 | $2 | $3 |
| Stock-Based Comp. | $0 | $447 | $1,323 | $1,179 |
| Change in WC | -$2,070 | -$8,098 | -$7,153 | $10,802 |
| Other Non-Cash | -$209 | -$27,314 | -$2,522 | $4,605 |
| Operating Cash Flow | -$24,367 | -$31,764 | -$56,770 | -$51,720 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$217 | -$85 | -$298 | -$1,141 |
| Net Acquisitions | $32 | $37,630 | $0 | $2 |
| Inv. Purchases | -$4 | -$5 | -$192 | -$421 |
| Inv. Sales/Matur. | $360 | $586 | $145 | $4 |
| Other Inv. Act. | $0 | $1 | $0 | $81 |
| Investing Cash Flow | $171 | $38,127 | -$345 | -$1,475 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $34,631 | $118 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,777 | -$1,768 | $44,712 | $25,449 |
| Financing Cash Flow | -$3,777 | -$1,768 | $44,712 | $25,449 |
| Forex Effect | $0 | $495 | $1,656 | -$981 |
| Net Chg. in Cash | -$28,315 | $5,090 | -$10,747 | -$28,727 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $38,789 | $33,699 | $44,446 | $73,173 |
| End Cash | $10,474 | $38,789 | $33,699 | $44,446 |
| Free Cash Flow | -$24,584 | -$31,849 | -$57,068 | -$52,861 |